Femtosecond pulsed laser microscopy: a new tool to assess the in vitro delivered dose of carbon nanotubes in cell culture experiments.


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 22 06 2020
accepted: 11 02 2021
entrez: 19 2 2021
pubmed: 20 2 2021
medline: 1 9 2021
Statut: epublish

Résumé

In vitro models are widely used in nanotoxicology. In these assays, a careful documentation of the fraction of nanomaterials that reaches the cells, i.e. the in vitro delivered dose, is a critical element for the interpretation of the data. The in vitro delivered dose can be measured by quantifying the amount of material in contact with the cells, or can be estimated by applying particokinetic models. For carbon nanotubes (CNTs), the determination of the in vitro delivered dose is not evident because their quantification in biological matrices is difficult, and particokinetic models are not adapted to high aspect ratio materials. Here, we applied a rapid and direct approach, based on femtosecond pulsed laser microscopy (FPLM), to assess the in vitro delivered dose of multi-walled CNTs (MWCNTs). We incubated mouse lung fibroblasts (MLg) and differentiated human monocytic cells (THP-1) in 96-well plates for 24 h with a set of different MWCNTs. The cytotoxic response to the MWCNTs was evaluated using the WST-1 assay in both cell lines, and the pro-inflammatory response was determined by measuring the release of IL-1β by THP-1 cells. Contrasting cell responses were observed across the MWCNTs. The sedimentation rate of the different MWCNTs was assessed by monitoring turbidity decay with time in cell culture medium. These turbidity measurements revealed some differences among the MWCNT samples which, however, did not parallel the contrasting cell responses. FPLM measurements in cell culture wells revealed that the in vitro delivered MWCNT dose did not parallel sedimentation data, and suggested that cultured cells contributed to set up the delivered dose. The FPLM data allowed, for each MWCNT sample, an adjustment of the measured cytotoxicity and IL-1β responses to the delivered doses. This adjusted in vitro activity led to another toxicity ranking of the MWCNT samples as compared to the unadjusted activities. In macrophages, this adjusted ranking was consistent with existing knowledge on the impact of surface MWCNT functionalization on cytotoxicity, and might better reflect the intrinsic activity of the MWCNT samples. The present study further highlights the need to estimate the in vitro delivered dose in cell culture experiments with nanomaterials. The FPLM measurement of the in vitro delivered dose of MWCNTs can enrich experimental results, and may refine our understanding of their interactions with cells.

Sections du résumé

BACKGROUND
In vitro models are widely used in nanotoxicology. In these assays, a careful documentation of the fraction of nanomaterials that reaches the cells, i.e. the in vitro delivered dose, is a critical element for the interpretation of the data. The in vitro delivered dose can be measured by quantifying the amount of material in contact with the cells, or can be estimated by applying particokinetic models. For carbon nanotubes (CNTs), the determination of the in vitro delivered dose is not evident because their quantification in biological matrices is difficult, and particokinetic models are not adapted to high aspect ratio materials. Here, we applied a rapid and direct approach, based on femtosecond pulsed laser microscopy (FPLM), to assess the in vitro delivered dose of multi-walled CNTs (MWCNTs).
METHODS AND RESULTS
We incubated mouse lung fibroblasts (MLg) and differentiated human monocytic cells (THP-1) in 96-well plates for 24 h with a set of different MWCNTs. The cytotoxic response to the MWCNTs was evaluated using the WST-1 assay in both cell lines, and the pro-inflammatory response was determined by measuring the release of IL-1β by THP-1 cells. Contrasting cell responses were observed across the MWCNTs. The sedimentation rate of the different MWCNTs was assessed by monitoring turbidity decay with time in cell culture medium. These turbidity measurements revealed some differences among the MWCNT samples which, however, did not parallel the contrasting cell responses. FPLM measurements in cell culture wells revealed that the in vitro delivered MWCNT dose did not parallel sedimentation data, and suggested that cultured cells contributed to set up the delivered dose. The FPLM data allowed, for each MWCNT sample, an adjustment of the measured cytotoxicity and IL-1β responses to the delivered doses. This adjusted in vitro activity led to another toxicity ranking of the MWCNT samples as compared to the unadjusted activities. In macrophages, this adjusted ranking was consistent with existing knowledge on the impact of surface MWCNT functionalization on cytotoxicity, and might better reflect the intrinsic activity of the MWCNT samples.
CONCLUSION
The present study further highlights the need to estimate the in vitro delivered dose in cell culture experiments with nanomaterials. The FPLM measurement of the in vitro delivered dose of MWCNTs can enrich experimental results, and may refine our understanding of their interactions with cells.

Identifiants

pubmed: 33602232
doi: 10.1186/s12989-021-00402-5
pii: 10.1186/s12989-021-00402-5
pmc: PMC7890618
doi:

Substances chimiques

Nanotubes, Carbon 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

9

Références

Nanoscale. 2019 Mar 21;11(12):5209-5214
pubmed: 30865200
Toxicol Sci. 2008 Jul;104(1):155-62
pubmed: 18400775
Chem Res Toxicol. 2008 Sep;21(9):1698-705
pubmed: 18636756
Nat Commun. 2014 Mar 28;5:3514
pubmed: 24675174
Part Fibre Toxicol. 2016 Feb 29;13:11
pubmed: 26926090
ACS Nano. 2014 Jun 24;8(6):5715-24
pubmed: 24853551
Environ Health Perspect. 2011 Nov;119(11):1539-46
pubmed: 21788197
Nanotoxicology. 2018 Sep;12(7):677-698
pubmed: 29804493
Toxicol Appl Pharmacol. 2005 Sep 15;207(3):221-31
pubmed: 16129115
Small. 2011 Aug 22;7(16):2348-55
pubmed: 21626688
Nanomaterials (Basel). 2020 Dec 03;10(12):
pubmed: 33287183
Part Fibre Toxicol. 2010 Nov 30;7(1):36
pubmed: 21118529
Nat Nanotechnol. 2011 Jun 06;6(6):332-3
pubmed: 21654645
Part Fibre Toxicol. 2018 Jan 25;15(1):6
pubmed: 29368623
Nanomaterials (Basel). 2019 Dec 11;9(12):
pubmed: 31835823
ACS Nano. 2013 Oct 22;7(10):8849-56
pubmed: 23992048
Nanotoxicology. 2020 Nov;14(9):1227-1240
pubmed: 32909484
Part Fibre Toxicol. 2020 Nov 26;17(1):60
pubmed: 33243293
Biomaterials. 2015;53:437-52
pubmed: 25890741
Part Fibre Toxicol. 2017 Dec 8;14(1):52
pubmed: 29216928
J Colloid Interface Sci. 2015 Jan 1;437:156-162
pubmed: 25313479
Nat Nanotechnol. 2011 Sep 18;6(11):714-9
pubmed: 21926979
Nano Lett. 2016 May 11;16(5):3173-8
pubmed: 27104759
Part Fibre Toxicol. 2014 Aug 12;11:35
pubmed: 25138533
Part Fibre Toxicol. 2018 Feb 9;15(1):11
pubmed: 29426343
Toxicol Sci. 2007 Feb;95(2):300-12
pubmed: 17098817
Toxicol Appl Pharmacol. 2012 Feb 15;259(1):96-103
pubmed: 22209804
Part Fibre Toxicol. 2013 Oct 10;10:52
pubmed: 24112397
Anal Chem. 2009 Apr 15;81(8):2944-52
pubmed: 19296592
Part Fibre Toxicol. 2014 Mar 27;11:14
pubmed: 24669904
Nanotoxicology. 2010 Jun;4(2):207-46
pubmed: 20795897

Auteurs

Dominique Lison (D)

Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium. dominique.lison@uclouvain.be.

Saloua Ibouraadaten (S)

Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.

Sybille van den Brule (S)

Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium.

Milica Todea (M)

Interdisciplinary Research Institute in Bio- Nano- Sciences, Babes-Bolyai University (BBU), Cluj-Napoca, Romania.
Department of Molecular Sciences, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Germany.

Adriana Vulpoi (A)

Interdisciplinary Research Institute in Bio- Nano- Sciences, Babes-Bolyai University (BBU), Cluj-Napoca, Romania.

Flaviu Turcu (F)

Interdisciplinary Research Institute in Bio- Nano- Sciences, Babes-Bolyai University (BBU), Cluj-Napoca, Romania.

Christina Ziemann (C)

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany.

Otto Creutzenberg (O)

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany.

James C Bonner (JC)

Toxicology Program, Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.

Marcel Ameloot (M)

Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.

Hannelore Bové (H)

Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.

Articles similaires

High-throughput Bronchus-on-a-Chip system for modeling the human bronchus.

Akina Mori, Marjolein Vermeer, Lenie J van den Broek et al.
1.00
Humans Bronchi Lab-On-A-Chip Devices Epithelial Cells Goblet Cells
Endometriosis Female Humans Animals Mice
Monocytes Humans Animals
Humans Stomach Neoplasms Macrophages Tumor Microenvironment Disease Progression

Classifications MeSH